Ziapin2 effectively restores retinal function in preclinical models of retinitis pigmentosa ...
A multidisciplinary team of researchers from the Istituto Italiano di Tecnologia (IIT-Italian Institute of Technology) and ...
GlobalData on MSN1 天
FDA RMAT designation for Beacon’s retinitis pigmentosa treatment
The US Food and Drug Administration (FDA) has granted regenerative medicine advanced therapy (RMAT) designation to Beacon ...
EurekAlert!9 天
Ziapin2 effectiveness in restoring retinal function in preclinical models of retinitis ...
A multidisciplinary team of researchers from the Istituto Italiano di Tecnologia (IIT-Italian Institute of Technology) and ...
Retinal diseases: RNA therapeutics show promise but is India ready?
Discover the importance of vision, genetic eye disorders, and RNA-based therapies for precision treatment in India and ...
Medscape2 天
The Cost-effectiveness of the Argus II Retinal Prosthesis in Retinitis Pigmentosa Patients
Argus II is a novel healthcare technology that restores vision in RP patients. Improvements in visual acuity are expected to lead to improvements in patient self-confidence, decreasing their ...
ophthalmologytimes6 天
FDA grants fast track designation to N-acetylcysteine amide tablets from Nacuity ...
The NPI-001 (N-acetylcysteine amide) tablets are a proprietary investigational therapy for the treatment of patients with ...
Nature6 天
Retinal Degeneration and Gene Therapy
Retinal degeneration encompasses a range of ... Among these conditions, retinitis pigmentosa (RP) and age-related macular degeneration (AMD) are particularly prevalent. Recent advancements in ...